|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
DE69233528T2
(de)
|
1991-11-25 |
2006-03-16 |
Enzon, Inc. |
Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
EP0739981A1
(en)
|
1995-04-25 |
1996-10-30 |
Vrije Universiteit Brussel |
Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
|
|
US20030224000A1
(en)
|
2001-12-21 |
2003-12-04 |
Kokai-Kun John Fitzgerald |
Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
|
|
AU2007281433A1
(en)
|
2006-08-04 |
2008-02-07 |
Nastech Pharmaceutical Company Inc. |
Compositions for intranasal delivery of human insulin and uses thereof
|
|
WO2011133886A2
(en)
|
2010-04-23 |
2011-10-27 |
Genentech, Inc. |
Production of heteromultimeric proteins
|
|
SI2766397T1
(sl)
|
2011-10-11 |
2018-09-28 |
F. Hoffmann-La Roche Ag |
Izboljšano sestavljanje bispecifičnih protiteles
|
|
JP7332157B2
(ja)
|
2017-01-24 |
2023-08-23 |
ノースウェスタン ユニバーシティ |
アンジオテンシン変換酵素2(ace2)の活性な低分子量変異体
|
|
US20200095327A1
(en)
|
2017-02-08 |
2020-03-26 |
Dragonfly Therapeutics, Inc. |
Antibody heavy chain variable domains targeting the nkg2d receptor
|
|
US20250263466A1
(en)
|
2020-02-03 |
2025-08-21 |
Vir Biotechnology, Inc. |
Antibodies against sars-cov-2 and methods of using the same
|
|
KR20220140568A
(ko)
|
2020-02-11 |
2022-10-18 |
벤더르빌트 유니버시티 |
중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2)에 대한 인간 단일클론 항체
|
|
PH12022552164A1
(en)
|
2020-02-19 |
2023-11-29 |
United Biomedical Inc |
Designer peptides and proteins for the detection, prevention and treatment of coronavirus disease, 2019 (covid-19)
|
|
HUE062777T2
(hu)
|
2020-02-26 |
2023-12-28 |
Vir Biotechnology Inc |
SARS-CoV-2 elleni antitestek
|
|
JP2023517234A
(ja)
|
2020-03-09 |
2023-04-24 |
アブセレラ バイオロジクス インコーポレイテッド |
抗コロナウイルス抗体および使用の方法
|
|
US11365239B2
(en)
|
2020-03-20 |
2022-06-21 |
Tsb Therapeutics (Beijing) Co., Ltd. |
Anti-SARS-COV-2 antibodies and uses thereof
|
|
CN111303280B
(zh)
|
2020-03-22 |
2022-01-07 |
中国人民解放军军事科学院军事医学研究院 |
高中和活性抗SARS-CoV-2全人源单克隆抗体及应用
|
|
EP4127174A4
(en)
*
|
2020-03-23 |
2024-05-01 |
Monash University |
ANTISENSE OLIGOMERS FOR THE TREATMENT OF DISEASES
|
|
WO2021195418A1
(en)
|
2020-03-26 |
2021-09-30 |
Vanderbilt University |
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
|
|
WO2021195326A1
(en)
|
2020-03-26 |
2021-09-30 |
Vanderbilt University |
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
|
|
US20230122364A1
(en)
|
2020-03-27 |
2023-04-20 |
Vanderbilt University |
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
|
|
CR20220552A
(es)
|
2020-04-02 |
2023-01-17 |
Regeneron Pharma |
Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno
|
|
WO2021216547A1
(en)
|
2020-04-20 |
2021-10-28 |
Sorrento Therapeutics, Inc. |
Pulmonary administration of ace2 polypeptides
|
|
TW202212354A
(zh)
*
|
2020-08-03 |
2022-04-01 |
美商健生生物科技公司 |
用於病毒治療劑中之多向生物運輸的材料及方法
|
|
WO2022075667A1
(ko)
*
|
2020-10-05 |
2022-04-14 |
한양대학교 산학협력단 |
안정화된 ace2 변이체, 이를 이용한 ace2-fc 융합단백질 및 covid-19 예방 또는 치료용 약학 조성물
|
|
WO2022082217A1
(en)
|
2020-10-16 |
2022-04-21 |
Eureka Therapeutics, Inc. |
Compositions for preventing or treating viral and other microbial infections
|